{"id":3623,"company":{"country":"US","currency":"USD","exchange":"NEW YORK STOCK EXCHANGE, INC.","ipo":"1941-01-01","marketCap":332050.90625,"name":"Merck \u0026 Co Inc","phone":"19087404000","outstanding":2532.81005859375,"symbol":"MRK","website":"https://www.merck.com/","industry":"Pharmaceuticals"},"price":130.755,"year":2024,"month":5,"day":23,"weekday":"Thursday","title":"The Role of Merck \u0026 Co Inc Stock in a Diversified Investment Portfolio","date":"2024-05-23","url":"/posts/2024/05/23/MRK","content":[{"section":"Introduction","text":"Merck \u0026 Co Inc is a leading pharmaceutical company that develops and markets a wide range of innovative medicines and vaccines. Investing in Merck \u0026 Co Inc stock can provide investors with an opportunity to participate in the pharmaceutical industry's growth and benefit from the company's success."},{"section":"Potential for Long-Term Growth","text":"Merck \u0026 Co Inc is known for its strong research and development pipeline, which helps the company continuously bring new and improved treatments to the market. This positions the company for long-term growth as it capitalizes on emerging therapeutic areas and addresses unmet medical needs. By including Merck \u0026 Co Inc stock in a diversified investment portfolio, investors can potentially benefit from the company's ability to generate sustainable revenue and profits over time."},{"section":"Stability and Defensive Characteristics","text":"Pharmaceutical companies, including Merck \u0026 Co Inc, often exhibit defensive characteristics that can help stabilize an investment portfolio during market downturns. The demand for healthcare products and services tends to be less sensitive to economic cycles, providing a cushion against market volatility. Merck \u0026 Co Inc's diverse product portfolio and global presence further contribute to its stability. Including Merck \u0026 Co Inc stock in a diversified investment portfolio can provide investors with a defensive asset that can help protect against downside risks."},{"section":"Dividend Income","text":"Merck \u0026 Co Inc has historically been a reliable dividend payer, offering investors a regular income stream. Dividends can be particularly attractive to income-focused investors who prioritize consistent and predictable cash flow. By investing in Merck \u0026 Co Inc stock, individuals can potentially benefit from its dividend payments, which can supplement other sources of income and contribute to the overall returns of a diversified investment portfolio."},{"section":"Risks to Consider","text":"While Merck \u0026 Co Inc stock has the potential to provide growth and stability, it is important for investors to consider the risks associated with investing in any individual stock. Factors such as changes in government regulations, patent expirations, and competition in the pharmaceutical industry can impact the company's performance. It is advisable to diversify investments across different sectors and companies to mitigate the risks associated with any single stock, including Merck \u0026 Co Inc."},{"section":"Conclusion","text":"Including Merck \u0026 Co Inc stock in a diversified investment portfolio can provide investors with an opportunity to benefit from the company's potential for long-term growth, stability during market downturns, and dividend income. However, it is important to assess the risks and consider diversification to build a well-rounded investment strategy. Consulting with a financial advisor can help individuals make informed decisions and determine the appropriate allocation of Merck \u0026 Co Inc stock in their portfolios."}],"tags":["LongSignals","Long","Pharmaceuticals"],"news":[{"category":"company","date":1716409532,"headline":"Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2024 Update","id":127854773,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"Jeremy Grantham's 13F portfolio value surged to $27.52B as top holdings include Microsoft, Alphabet, Meta Platforms, UnitedHealth, and Apple. Explore more here.","url":"https://seekingalpha.com/article/4695130-tracking-jeremy-granthams-gmo-capital-portfolio-q1-2024-update"},{"category":"company","date":1716385811,"headline":"Why Merck (MRK) is a Top Momentum Stock for the Long-Term","id":127845826,"image":"https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619","symbol":"MRK","publisher":"Yahoo","summary":"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.","url":"https://finance.yahoo.com/news/why-merck-mrk-top-momentum-135011185.html"},{"category":"company","date":1716384900,"headline":"MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing","id":127845651,"image":"","symbol":"MRK","publisher":"Business Wire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=j5irrw2hd7"},{"category":"company","date":1716376620,"headline":"Florida men plead guilty to fraud in scheme to export biochemicals to China","id":127845652,"image":"","symbol":"MRK","publisher":"United Press International","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=hzjkgjgfxe"},{"category":"company","date":1716375635,"headline":"Merck \u0026 Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%","id":127845828,"image":"https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","symbol":"MRK","publisher":"Yahoo","summary":"Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the...","url":"https://finance.yahoo.com/news/merck-co-inc-nyse-mrk-110035193.html"},{"category":"company","date":1716351480,"headline":"Wells Fargo Sticks to Their Hold Rating for Merck \u0026 Company (MRK)","id":127845653,"image":"","symbol":"MRK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3507044215"},{"category":"company","date":1716292870,"headline":"MSD collaboration to drive development of solid tumour combination therapy","id":127814922,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"Biotech company Dragonfly Therapeutics Inc has agreed to collaborate with Merck , to evaluate a first-in-class EGFR-targeting treatment in combination with KEYTRUDA® (...","url":"https://finnhub.io/api/news?id=a69e03c5b932d9373eb8d42a4e3fe82404dc9ca01ef5498863ae510e6768a4a6"},{"category":"company","date":1716285600,"headline":"Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs","id":127813774,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440974/image_1292440974.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"Pfizer shares lagged behind pharma rally due to inflated expectations, one-time losses, write-offs, and the Seagen acquisition. Find out why PFE stock is a Buy.","url":"https://seekingalpha.com/article/4694563-pfizer-offsetting-the-loe-cliff-crisis-with-6-new-potential-blockbuster-drugs"},{"category":"company","date":1716282000,"headline":"Global company events calendar","id":127815319,"image":"","symbol":"MRK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=uu0jdymlkj"},{"category":"company","date":1716210840,"headline":"Here's Why Merck (MRK) Stock Has Outperformed Industry YTD","id":127804270,"image":"https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307","symbol":"MRK","publisher":"Yahoo","summary":"Merck (MRK) stock is being driven by the strong sales of key products like Keytruda and Gardasil and positive pipeline and regulatory developments.","url":"https://finance.yahoo.com/news/heres-why-merck-mrk-stock-131400542.html"},{"category":"company","date":1716209940,"headline":"Large Cap Biopharmaceuticals Performance","id":127800425,"image":"","symbol":"MRK","publisher":"TalkMarkets","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504269388"},{"category":"company","date":1716202140,"headline":"The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express, Walmart, Amazon, The Goldman Sachs and Merck \u0026 Co","id":127798110,"image":"https://media.zenfs.com/en/zacks.com/38c7ef8f4b67550bc3d573f485b8ea7f","symbol":"MRK","publisher":"Yahoo","summary":"American Express, Walmart, Amazon, The Goldman Sachs and Merck \u0026 Co are included in this Analyst Blog.","url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-stocks-104900671.html"},{"category":"company","date":1716176460,"headline":"Merck \u0026 Co. Inc. stock outperforms competitors despite losses on the day","id":127822255,"image":"","symbol":"MRK","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3504472846"},{"category":"company","date":1716084420,"headline":"SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?","id":127790807,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3503224853"},{"category":"company","date":1715997240,"headline":"Novo Nordisk, J\u0026J lead R\u0026D rankings in big pharma: report","id":127778728,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3502273184"},{"category":"company","date":1715985027,"headline":"Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness","id":127766648,"image":"https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","symbol":"MRK","publisher":"Yahoo","summary":"The fact that multiple Merck \u0026 Co., Inc. ( NYSE:MRK ) insiders offloaded a considerable amount of shares over the past...","url":"https://finance.yahoo.com/news/insiders-merck-sold-us-12m-223027861.html"},{"category":"company","date":1715958600,"headline":"5 Stocks Powering the Dow ETF Year to Date","id":127765177,"image":"https://media.zenfs.com/en/zacks.com/da295f4f52d7328c0254302313c838ec","symbol":"MRK","publisher":"Yahoo","summary":"The Dow Jones touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts. We have highlighted five ETFs that have been leading the way higher this year.","url":"https://finance.yahoo.com/news/5-stocks-powering-dow-etf-151000751.html"},{"category":"company","date":1715949660,"headline":"10 Health Care Stocks Whale Activity In Today's Session","id":127760352,"image":"","symbol":"MRK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500786994"},{"category":"company","date":1715940000,"headline":"Storm Shelter: 7 Safe Haven Stocks to Batten Down the Hatches","id":127862961,"image":"https://media.zenfs.com/en/investorplace_417/807454d44aa2d22b36d5404d08183230","symbol":"MRK","publisher":"Yahoo","summary":"With the market potentially entering a period of consolidation, investors may want to consider safe haven stocks to buy. No, it’s not the most exciting idea. Yet surviving to live another day is a valuable skill on Wall Street. First and foremost, safe havens provide stability and predictability. Generally, we’re talking about enterprises that feature stable earnings and cash flows. Further, because of their established businesses, they’re much more predictable. While this predictability comes a","url":"https://finance.yahoo.com/news/storm-shelter-7-safe-haven-100000854.html"},{"category":"company","date":1715930400,"headline":"GLOBAL BROKER RATINGS: RBC cuts Inditex, Deutsche raises Roche","id":127756297,"image":"","symbol":"MRK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=rae0wwk9gj"},{"category":"company","date":1715928000,"headline":"Dow at 40K: Leaders and laggards over the last 10,000 points","id":127756867,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500374304"},{"category":"company","date":1715919600,"headline":"Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 05/17/2024","id":127760356,"image":"","symbol":"MRK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3500254806"},{"category":"company","date":1715871096,"headline":"Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game","id":127737294,"image":"https://media.zenfs.com/en/Benzinga/b4ddeefb7aa891b262c5698a36b75643","symbol":"MRK","publisher":"Yahoo","summary":"On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose France” business summit. Together with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87 billion which is more than $2 billion to expand their operations in the country. AstraZeneca committed 365 million euros, which is about $394 mi","url":"https://finance.yahoo.com/news/pfizer-astrazeneca-sanofi-mainz-biomed-145136527.html"},{"category":"company","date":1715866503,"headline":"Merck (MRK) Crossed Above the 20-Day Moving Average: What That Means for Investors","id":127741465,"image":"https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177","symbol":"MRK","publisher":"Yahoo","summary":"When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?","url":"https://finance.yahoo.com/news/merck-mrk-crossed-above-20-133503406.html"},{"category":"company","date":1715864700,"headline":"The Dow closed above 40,000 for the first time. The number is big but means little for your 401(k)","id":127763323,"image":"","symbol":"MRK","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=5t9lgsyoh5"},{"category":"company","date":1715864700,"headline":"The Dow just crossed 40,000 for the first time. The number is big but means little for your 401(k)","id":127741168,"image":"","symbol":"MRK","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=zoyrjgp09i"},{"category":"company","date":1715856540,"headline":"The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG\u0026E","id":127740464,"image":"https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a","symbol":"MRK","publisher":"Yahoo","summary":"Broadcom, Merck, Airbnb, ONEOK and PG\u0026E are included in this Analyst Blog.","url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-broadcom-104900287.html"},{"category":"company","date":1715846820,"headline":"Bank of America Securities Keeps Their Buy Rating on Merck \u0026 Company (MRK)","id":127748052,"image":"","symbol":"MRK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3498635202"},{"category":"company","date":1715843760,"headline":"GLOBAL BROKER RATINGS: Metzler cuts Knorr-Bremse; Oddo raises Stroer","id":127738177,"image":"","symbol":"MRK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=7gee0b6cyj"},{"category":"company","date":1715825400,"headline":"Which Is The Best Investment For You? High Yield Pfizer Or Higher Growth Merck?","id":127748055,"image":"","symbol":"MRK","publisher":"TalkMarkets","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499153712"},{"category":"company","date":1715823540,"headline":"Check Out What Whales Are Doing With MRK","id":127748056,"image":"","symbol":"MRK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3499107822"},{"category":"company","date":1715812506,"headline":"Merck \u0026 Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript)","id":127724522,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"MRK","publisher":"SeekingAlpha","summary":"Merck \u0026amp; Co., Inc. (NYSE:NYSE:MRK) BofA Securities 2024 Health Care Conference May 15, 2024 4:40 PM ETCompany ParticipantsCaroline Litchfield - EVP \u0026amp;...","url":"https://seekingalpha.com/article/4693716-merck-and-co-inc-mrk-bofa-securities-2024-health-care-conference-transcript"},{"category":"company","date":1715793060,"headline":"Top Stock Reports for Broadcom, Merck \u0026 Airbnb","id":127713054,"image":"https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a","symbol":"MRK","publisher":"Yahoo","summary":"Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck \u0026 Co., Inc. (MRK) and Airbnb, Inc. (ABNB).","url":"https://finance.yahoo.com/news/top-stock-reports-broadcom-merck-171100771.html"},{"category":"company","date":1715787420,"headline":"2 Fortune 100 Best Co's To Work For Are Also Good To Own","id":127713849,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1187807387/image_1187807387.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"Discover the top dividend-paying stocks from Fortune's BCTWF list, offering impressive yields and potential gains in 2024. Click here for the list.","url":"https://seekingalpha.com/article/4693591-2-fortune-100-best-cos-to-work-for-are-also-good-to-own"},{"category":"company","date":1715776620,"headline":"10 Health Care Stocks With Whale Alerts In Today's Session","id":127713635,"image":"","symbol":"MRK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497109526"},{"category":"company","date":1715776020,"headline":"MannKind Outperforms As Tyvaso DPI Captures Market Share","id":127709938,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496318318"},{"category":"company","date":1715769900,"headline":"Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline","id":127707427,"image":"https://media.zenfs.com/en/business-wire.com/382bf33f895ddf3ce2507035c988fc15","symbol":"MRK","publisher":"Yahoo","summary":"RAHWAY, N.J., May 15, 2024--Merck to Present New Data at 2024 ASCO Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline","url":"https://finance.yahoo.com/news/merck-present-data-2024-asco-104500141.html"},{"category":"company","date":1715768340,"headline":"Least shorted S\u0026P 500 stocks as a percentage of float","id":127708755,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496905377"},{"category":"company","date":1715767499,"headline":"Merck to present new oncology data","id":127707389,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"Merck announces that it will present new data on four approved oncology drugs and four drug candidates in development at the American Society of Clinical Oncology 2024 Annual Meeting. These data will...","url":"https://finnhub.io/api/news?id=23dad8306c335bb113d5e40c3f6fd9cda9494610861a4c0135d5257dab92c322"},{"category":"company","date":1715765220,"headline":"Short interest in S\u0026P 500 healthcare sector dips in April, biotechnology companies most shorted","id":127713568,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3496830680"},{"category":"company","date":1715762736,"headline":"Pfizer: Best Trading Momentum Since 2021 And 6% Yield","id":127706499,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157339504/image_157339504.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. See why I continue to rate PFE stock a strong buy.","url":"https://seekingalpha.com/article/4693405-pfizer-best-trading-momentum-since-2021-and-6-percent-yield"},{"category":"company","date":1715746680,"headline":"Profit down at pharmaceutical firm Merck in first quarter","id":127721503,"image":"","symbol":"MRK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=szidjc10ov"},{"category":"company","date":1715738520,"headline":"Organon \u0026 Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024","id":127714755,"image":"","symbol":"MRK","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3497239136"},{"category":"company","date":1715733180,"headline":"GLOBAL BRIEFING: Boeing may be prosecuted over crashes, US DoJ says","id":127711832,"image":"","symbol":"MRK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=rdqd5h1w7m"},{"category":"company","date":1715693100,"headline":"Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility","id":127681278,"image":"https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c","symbol":"MRK","publisher":"Yahoo","summary":"Merck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.","url":"https://finance.yahoo.com/news/merck-mrk-ends-keytruda-combo-132500242.html"},{"category":"company","date":1715678516,"headline":"Merck cancels trial of melanoma treatment due to immune-mediated adverse events","id":127679375,"image":"https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/05/Merck-1.jpg","symbol":"MRK","publisher":"Yahoo","summary":"An increased rate of discontinuation due to immune-mediated adverse events was seen in the trial's coformulation arm.","url":"https://www.clinicaltrialsarena.com/news/merck-melanoma-regimen-trial/"},{"category":"company","date":1715677380,"headline":"Health care is still very crowded but trades at a discount vs. history - BofA","id":127681812,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3494941581"},{"category":"company","date":1715672460,"headline":"Analysts Are Bullish on Top Healthcare Stocks: Merck \u0026 Company (MRK), Inovio Pharmaceuticals (INO)","id":127690198,"image":"","symbol":"MRK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3494837598"},{"category":"company","date":1715649367,"headline":"Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer","id":127673973,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"Oslo, Norway, May 14, 2024 - Nykode Therapeutics ASA , aclinical-stage biopharmaceutical company dedicated to the discovery anddevelopment of novel immunotherapies, today announced that it has...","url":"https://finnhub.io/api/news?id=f172060d67c1b8f4a3e5f034d292f6a27730e510935ad1dc0a4fa6142255822c"},{"category":"company","date":1715620168,"headline":"Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment","id":127672137,"image":"https://media.zenfs.com/en/Benzinga/b053b2bd10248bb9c9e64e8dc8237826","symbol":"MRK","publisher":"Yahoo","summary":"Monday, Merck \u0026 Co Inc (NYSE:MRK) announced the discontinuation of the vibostolimab and pembrolizumab coformulation arm of the Phase 3 KeyVibe-010 trial. The trial evaluates the investigational coformulation of vibostolimab and Keytruda (pembrolizumab) compared to Keytruda alone as adjuvant treatment for patients with resected high-risk melanoma (Stage IIB-IV). Also Read: Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook. Data from a pre-planned analysis showed tha","url":"https://finance.yahoo.com/news/merck-halts-skin-cancer-drug-170928079.html"},{"category":"company","date":1715601360,"headline":"See Which Of The Latest 13F Filers Holds Merck \u0026 Co","id":127671327,"image":"","symbol":"MRK","publisher":"Preferred Stock Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493233677"},{"category":"company","date":1715598120,"headline":"Barrow, Hanley, Mewhinney \u0026 Strauss Bolsters Portfolio with Strategic Additions in Q1 2024","id":127658657,"image":"","symbol":"MRK","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493152383"},{"category":"company","date":1715597100,"headline":"Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma","id":127655799,"image":"https://media.zenfs.com/en/business-wire.com/e3f533a6c1380fea27b3710161fbd2aa","symbol":"MRK","publisher":"Yahoo","summary":"RAHWAY, N.J., May 13, 2024--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma","url":"https://finance.yahoo.com/news/merck-provides-phase-3-keyvibe-104500620.html"},{"category":"company","date":1715591700,"headline":"Video: Dow Movers: MRK, INTC","id":127671332,"image":"","symbol":"MRK","publisher":"Market News Video","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492998241"},{"category":"company","date":1715590975,"headline":"Merck: phase 3 trial in melanoma halted","id":127656425,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"On Monday, Merck announced the discontinuation of a phase 3 clinical trial combining its flagship immunotherapy Keytruda with its new molecule vibostolimab in the treatment of high-risk stage 2 to 4...","url":"https://finnhub.io/api/news?id=0f193ee0add6b30521320e651fc38b713bebc835f6f3240914f2332508cb500a"},{"category":"company","date":1715587522,"headline":"Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study","id":127655907,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"By Colin Kellaher Merck \u0026 Co. has ended part of a late-stage study of a co-formulation of its blockbuster cancer drug Keytruda in certain skin-cancer patients because the study was likely to...","url":"https://finnhub.io/api/news?id=f71463fc2d4755fc65f3a488782845be1d6c67bb89fd7d822e752a411a21c857"},{"category":"company","date":1715583874,"headline":"Merck stops skin cancer combination therapy testing in late-stage study","id":127655511,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"Merck said on Monday it haddiscontinued the arm of a late-stage study, which tested anexperimental antibody-based drug with its blockbusterimmunotherapy Keytruda for some patients with the most...","url":"https://finnhub.io/api/news?id=f8728bdfa9ebe4f82697f5bee3d7de06d9ba33fbc0b116fc7a1229d404c46d69"},{"category":"company","date":1715583840,"headline":"Merck discontinues testing of experimental skin cancer combo therapy","id":127658685,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492830031"},{"category":"company","date":1715579400,"headline":"Merck discontinues vibostolimab-Keytruda combination arm of Phase 3 trial","id":127671335,"image":"","symbol":"MRK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492753353"},{"category":"company","date":1715573169,"headline":"My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech","id":127654216,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/164751847/image_164751847.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"I have shifted my strategy to focus on quality rather than value and have been buying big-tech stocks. Read more to see a review of my portfolio.","url":"https://seekingalpha.com/article/4692695-my-dividend-growth-portfolio-selling-bio-pharma-and-buying-more-big-tech"},{"category":"company","date":1715571840,"headline":"Healthcare And Biotech Investing 101: What You Need To Know.","id":127659416,"image":"","symbol":"MRK","publisher":"TalkMarkets","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3492650661"},{"category":"company","date":1715569320,"headline":"Robert Bruce's Strategic Moves in Q1 2024: Spotlight on Xcel Energy Inc","id":127667529,"image":"","symbol":"MRK","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3493530119"},{"category":"company","date":1715543997,"headline":"VYM: Spotting Alpha Among Inexpensive High-Dividend Stocks","id":127651403,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1478156131/image_1478156131.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"VYM seeks to track the performance of the FTSE High Dividend Yield Index. Click here to read why I reiterate a Buy rating on VYM ETF.","url":"https://seekingalpha.com/article/4692655-vym-spotting-alpha-among-inexpensive-high-dividend-stocks"},{"category":"company","date":1715504122,"headline":"5 April Quality Dividend Growth Stock Raises","id":127646500,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1489815764/image_1489815764.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"5 companies in Rose's Income Garden portfolio gave April raises, spanning different sectors. Click here for the complete list.","url":"https://seekingalpha.com/article/4692562-5-april-quality-dividend-growth-stock-raises"},{"category":"company","date":1715410713,"headline":"Organon Graduates From Spinoff Skepticism, With A Yield Above 5%","id":127633484,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/76008293/image_76008293.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"Organon offers attractive yields above 5%. Ample cash flow and improving earnings support the reliability of Organon's dividend. See more on OGN stock here.","url":"https://seekingalpha.com/article/4692169-organon-graduates-from-spinoff-skepticism-with-a-yield-above-5-percent"},{"category":"company","date":1715338820,"headline":"Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years","id":127609215,"image":"https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","symbol":"MRK","publisher":"Yahoo","summary":"By buying an index fund, investors can approximate the average market return. But if you pick the right individual...","url":"https://finance.yahoo.com/news/mercks-nyse-mrk-investors-pleased-110020556.html"},{"category":"company","date":1715335260,"headline":"The 3 Most Undervalued Healthcare Stocks to Buy in May 2024","id":127741471,"image":"https://media.zenfs.com/en/investorplace_417/5b06085ec403fd81519de4f4d5892664","symbol":"MRK","publisher":"Yahoo","summary":"A commonly used strategy for investing is sector rotation. This involves the movement of funds from one sector to another based on macroeconomic and other factors. A good example is the flow of funds into undervalued healthcare stocks during the pandemic. It didn’t take long for healthcare stocks to trade at premium valuations. Similarly, e-commerce and online education stocks surged during the pandemic. Once the concerns related to the pandemic eased, funds flowed to sectors negatively impacted","url":"https://finance.yahoo.com/news/3-most-undervalued-healthcare-stocks-100100651.html"},{"category":"company","date":1715333256,"headline":"Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA plus Chemotherapy, With or Without Radiotherapy, for Patients with Newly Diagnosed, High-Risk Endometrial Cancer","id":127602160,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, in combination with...","url":"https://finnhub.io/"},{"category":"company","date":1715320961,"headline":"Merck: The Worst Has Been Avoided (Rating Upgrade)","id":127598764,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1337117159/image_1337117159.jpg?io=getty-c-w1536","symbol":"MRK","publisher":"SeekingAlpha","summary":"Merck continues toÂ make tremendous progressÂ in developing its rich portfolio of experimental drugs and vaccines. See why MRK stock is a Buy.","url":"https://seekingalpha.com/article/4691766-merck-stock-q1-earnings-worst-has-been-avoided-rating-upgrade-buy"},{"category":"company","date":1715319240,"headline":"3 Biotech Stocks to Sell in May Before They Crash \u0026 Burn","id":127604980,"image":"","symbol":"MRK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3488779514"},{"category":"company","date":1715259616,"headline":"Investors Heavily Search Merck \u0026 Co., Inc. (MRK): Here is What You Need to Know","id":127572038,"image":"https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295","symbol":"MRK","publisher":"Yahoo","summary":"Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.","url":"https://finance.yahoo.com/news/investors-heavily-search-merck-co-130016293.html"},{"category":"company","date":1715252700,"headline":"Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy","id":127569825,"image":"https://media.zenfs.com/en/cnwgroup.com/1dc1d1cd77ebf254a96f1b3fc1f216e1","symbol":"MRK","publisher":"Yahoo","summary":"Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with gemcitabine-based chemotherapy, for the treatment of adult patients with locally advanced unresectable or metastatic biliary tract carcinoma (BTC). This approval is based on the results from the Phase 3 KEYNOTE-966 trial, which demonstrated a statistically significant and clinically meaningful improvem","url":"https://finance.yahoo.com/news/health-canada-approves-keytruda-adult-110500485.html"},{"category":"company","date":1715251500,"headline":"Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent","id":127569826,"image":"https://media.zenfs.com/en/business-wire.com/ae251c5c808b6a812db9d865d680b6b4","symbol":"MRK","publisher":"Yahoo","summary":"RAHWAY, N.J., May 09, 2024--Merck Provides Update on Phase 3 KEYNOTE-B21 Trial","url":"https://finance.yahoo.com/news/merck-provides-phase-3-keynote-104500563.html"},{"category":"company","date":1715247360,"headline":"7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025","id":127575398,"image":"","symbol":"MRK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486600071"},{"category":"company","date":1715247360,"headline":"June 28th Options Now Available For Merck (MRK)","id":127577864,"image":"","symbol":"MRK","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486600330"},{"category":"company","date":1715243553,"headline":"Merck: trial in endometrial cancer fails","id":127568053,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"Merck announced on Thursday that a Phase III clinical trial evaluating its flagship immunotherapy Keytruda in the treatment of endometrial cancer had failed to meet its primary objective.The trial...","url":"https://finnhub.io/api/news?id=db44cc9d14ee2770145a9a555bae48ef78d6353e666d6f48987366c4533fb92e"},{"category":"company","date":1715242597,"headline":"Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint","id":127567701,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"By Robb M. Stewart Merck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with chemotherapy to...","url":"https://finnhub.io/api/news?id=fefcd476a507473eb5ba43e0980f4bf6a6a5683909c7383225af859a6b82d8d8"},{"category":"company","date":1715238925,"headline":"Merck: success of 'Merck for Mothers' initiative","id":127566462,"image":"","symbol":"MRK","publisher":"Finnhub","summary":"Merck announces that 'Merck for Mothers', its global maternal health initiative, has already exceeded its target of reaching more than 30 million women with programs promoting safe, respectful and...","url":"https://finnhub.io/api/news?id=e4e44dd18e585cab5d0f9e01c00b6191a8aa98e1c42a98f876b0e0f32f1b3188"},{"category":"company","date":1715235300,"headline":"Merck says Keytruda failed as first-line therapy for uterine cancer","id":127577869,"image":"","symbol":"MRK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486268495"},{"category":"company","date":1715233740,"headline":"Merck provides update on Phase 3 KEYNOTE-B21 trial","id":127577871,"image":"","symbol":"MRK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3486239913"}]}